TerminatedNot Applicable

Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia

Stopped: Retirement of one of the PIs and participation in another multi center study, within which the same patient inclusion criteria were used.

Germany130 participantsStarted 2011-10

Plain-language summary

Panic disorder with agoraphobia is a prevalent and one of the most handicapping anxiety disorders. Although the efficacy of psychological treatment for panic disorder with agoraphobia has been the subject of a great deal of research, studies comparing cognitive-behavioral therapy and exposure in vivo have regularly been underpowered to detect small to moderate differences. Therefore, the primary purpose of the present study is to investigate if the combination of cognitive techniques with exposure in vivo is superior to the effects of exposure alone for patients with moderate to severe agoraphobia.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of panic disorder with agoraphobia by trained clinician using a structured interview * The anxiety disorder is considered to be the patient's main current problem * Age between 18 and 65 years * The patient has agreed to participate in the study Exclusion Criteria: \- Diagnosis of bipolar disorder, psychotic disorder, alcohol/substance abuse or dependency (within past 3 months), prominent risk of self-harm, organic mental disorder; concurrent psychotherapeutic or psychopharmacological treatment

What they're measuring

Change (from baseline) in the Mobility Inventory

Timeframe: 0, 6, 12 month after treatment

Trial details

NCT IDNCT01680237

SponsorRuhr University of Bochum

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11

View on ClinicalTrials.gov More Panic Disorder With Agoraphobia trials